异种原始增强疫苗接种驱动 stromal 激活和适应性免疫力对抗 SARS-CoV-2 变种
Ji Hyang Jeon1,2, Seongryong Kim3, Seo-Yeon Kim1
1Division of Infectious Disease Vaccine Research, Center for Vaccine Research, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
Frontiers in immunology
|June 12, 2025
概括
异种疫苗接种 (腺病毒原始,mRNA增强) 增强了对COVID-19变种的免疫反应. 腺病毒启动条件免疫系统,在mRNA疫苗接种时增强T细胞和抗体反应.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 病毒学 病毒学
背景情况:
- 异质的初级增强疫苗接种策略显示出比同源方案更高的疗效.
- 驱动异种疫苗有效性的免疫机制尚不清楚.
研究的目的:
- 在小鼠模型中研究使用腺病毒和mRNA疫苗进行异种原始增强疫苗接种的免疫反应和机制.
- 为了比较免疫反应与SARS-CoV-2 Delta和Omicron-BA.5变种诱导的异质与同质疫苗接种.
主要方法:
- 采用了一种老鼠模型,用于异种 (腺病毒原始,mRNA提升) 和同源的疫苗接种方案.
- 评估中和抗体标位和CD8+T细胞反应.
- 对注射部位组织进行单细胞转录组分析,以检查局部免疫环境.
主要成果:
- 异种疫苗接种引起了显著更高的中和抗体标位和更强的CD8+T细胞对SARS-CoV-2 Delta和Omicron-BA.5变异的反应.
- 腺病毒原始化诱导了预先条件的先天免疫环境,细胞组成的变化最小.
- 增强mRNA增强了这些效应,特别是纤维细胞驱动的化学激素反应,增强了免疫细胞的招募.
结论:
- 在随后的mRNA增强时,腺病毒原始化增强了局部免疫激活,从而在异种疫苗接种中促进了优异的适应性免疫反应.
- 这项研究提供了对异种主要增强疫苗接种策略对SARS-CoV-2变种的有效性的机制性见解.
相关概念视频
Vaccinations
44.2K
Overview
44.2K
Cells of the Adaptive Immune Response
971
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
971
B Cell Activation and Differentiation
1.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.6K
Cell-mediated Immune Responses
67.8K
Overview
67.8K


